Benzoctamine and Chlordiazepoxide in Anxiety: Some Predictors of Improvement

Autor:	Jorge A. Pereira-Ogan, Charles C. Weise, Karl Rickels, Harold S. Feldman, W. George Case, Robert W. Downing
Rok vydání:	1973
Předmět:	business.industry Biochemistry (medical) Benzoctamine medicine Anxiety Cell Biology General Medicine medicine.symptom business Biochemistry Chlordiazepoxide medicine.drug Clinical psychology
Zdroj:	Journal of International Medical Research. 1:184-187
ISSN:	1473-2300 0300-0605
DOI:	10.1177/030006057300100308
Popis:	A multiple regression search analysis was conducted with 76 anxious outpatients treated in a 4 week clinical trial with either benzoctamine 60 mg/day or chlordiazepoxide 60 mg/day. Better response was predicted: For benzoctamine, in patients who are less educated, have an adequate occupational adjustment, and are initially higher in anxiety. For chlordiazepoxide, in patients who are more educated and have a marginal occupational adjustment. For both drugs, in patients who are black, are diagnosed as anxious rather than anxious-depressed, and are higher in initial depression. A major factor accounting for the differential effectiveness predicted for these 2 anti-anxiety agents was felt to be the large number of sedative side effects reported by patients receiving benzoctamine 60 mg/day.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::07b3371ef64a9d79dce0ea012ed3e7c3 https://doi.org/10.1177/030006057300100308 Zobrazit plný text záznamu